Latest total revenue for FMS: $19B, below the Healthcare sector average of $110B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Fresenius Medical Care AG (FMS) currently reports a total revenue of $19B as of June 2026. That compares with $20B in the prior-year period — down 0.5% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Fresenius Medical Care AG's total revenue history and peer comparisons.
Fresenius Medical Care AG's total revenue decreased from $20B to $19B — a 0.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Fresenius Medical Care AG's total revenue of $19B is lower than the Healthcare sector average of $110B. That is roughly 82.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Fresenius Medical Care AG reported $19B in total revenue as of June 2026. That compares with $20B in the prior-year period — down 0.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total revenue of $19B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Fresenius Medical Care AG, and consider following FMS for alerts when major investors trade the stock.